Effect of Ketamine+Propofol vs Remifentanyl+Propofol on Laryngeal Mask Insertion Conditions
1 other identifier
observational
50
1 country
1
Brief Summary
Laryngeal mask airway is a common tool for airway management during anesthesia in many surgeries. Insertion of laryngeal mask needs deep anesthesia, suppression of airway, stabile hemodynamic response. Many drug regimens has been used for this purpose. This study aimed to compare the insertion conditions of laryngeal mask by using ketamine+propofol versus remifentanil + propofol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 18, 2015
CompletedFirst Posted
Study publicly available on registry
October 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedMay 8, 2017
January 1, 2016
9 months
September 18, 2015
May 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
High laryngeal mask insertion scores
3 minutes
Secondary Outcomes (2)
Hypotension
10 minutes
Hypertension
10 minutes
Study Arms (2)
Ketamine
Ketamine+propofol
Remifentanyl
Remifentanyl+propofol
Interventions
To compare ketamine+propofol versus remifentanyl+propofol to maintain good laryngeal mask insertion conditions
Eligibility Criteria
Surgery performed with laryngeal mask as airway tool in gynecologic clinic
You may qualify if:
- Surgery requires laryngeal mask
You may not qualify if:
- Patient refusal, abdominal surgery required muscle relaxant, any allergy to ketamine or remifentanyl
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cigdem Yildirim Guclu
Ankara, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
CIGDEM YILDIRIM GUCLU, MD
Ankara University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
September 18, 2015
First Posted
October 22, 2015
Study Start
April 1, 2015
Primary Completion
January 1, 2016
Study Completion
January 1, 2016
Last Updated
May 8, 2017
Record last verified: 2016-01